Skip to Main content Skip to Navigation
Journal articles

Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study

P. Houssel-Debry 1, 2 C. Duvoux 3 A. Coilly 4 C. Fougerou-Leurent 1, 2 C. Jezequel 2 V. de Ledinghen S. Radenne 5 Nassim Kamar 6 V. Leroy V. Di Martino 7 L. d'Alteroche 8 V. Canva 9 F. Conti 10 J. Dumortier 5 H. Montialoux P. Lebray 10 D. Botta-Fridlund 11 R. Anty C. Moreno 12 C. Silvain 13, 14 C. Besch 15 P. Perré F. Durand A. Abergel 16 F. Habersetzer M. Debette-Gratien A. Rohel 17 A. Diallo 17 E. Rossignol 1 A. Veislinger 1 H. Danjou 1 J. -C. Duclos-Vallee G. -P. Pageaux
Abstract : EASL International Liver Congress, APR 13-17, 2016, Barcelona, SPAIN
Document type :
Journal articles
Complete list of metadata

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01533345
Contributor : Laurent Jonchère <>
Submitted on : Tuesday, June 6, 2017 - 12:33:39 PM
Last modification on : Friday, June 4, 2021 - 4:34:08 PM

Identifiers

Citation

P. Houssel-Debry, C. Duvoux, A. Coilly, C. Fougerou-Leurent, C. Jezequel, et al.. Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study. Journal of Hepatology, Elsevier, 2016, 64, pp.S144--S145. ⟨10.1016/S0168-8278(16)01652-4⟩. ⟨hal-01533345⟩

Share

Metrics

Record views

234